Search details
1.
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?
Curr Oncol Rep
; 23(12): 147, 2021 11 08.
Article
in English
| MEDLINE | ID: mdl-34748099
2.
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience.
J Oncol Pharm Pract
; 27(3): 609-613, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-32507099
3.
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.
J Transl Med
; 17(1): 296, 2019 08 29.
Article
in English
| MEDLINE | ID: mdl-31464635
4.
A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
Breast J
; 26(9): 1857-1859, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32436244
5.
Stereotactic body radiotherapy in oligoprogressive metastatic castration-resistant prostate cancer during abiraterone or enzalutamide.
Tumori
; 109(4): 413-417, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-36358013
6.
Feasibility of cabazitaxel in octogenarian prostate cancer patients.
Curr Urol
; 17(3): 153-158, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37448615
7.
A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer.
Anticancer Res
; 43(1): 501-508, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36585190
8.
Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem.
Case Rep Oncol
; 15(1): 312-317, 2022.
Article
in English
| MEDLINE | ID: mdl-35529294
9.
Current treatment options for HER2-positive breast cancer patients with brain metastases.
Crit Rev Oncol Hematol
; 161: 103329, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33862249
10.
Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis.
Future Sci OA
; 7(10): FSO750, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34840807
11.
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety.
Am J Clin Oncol
; 44(3): 105-108, 2021 03 01.
Article
in English
| MEDLINE | ID: mdl-33481372
12.
Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients' Queries, Needs, Fears, and Actions Taken.
JCO Glob Oncol
; 6: 722-729, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32412811
13.
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data.
In Vivo
; 34(4): 2009-2014, 2020.
Article
in English
| MEDLINE | ID: mdl-32606174
14.
Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World.
Anticancer Res
; 40(12): 7037-7043, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-33288600
15.
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis.
Ecancermedicalscience
; 14: 1113, 2020.
Article
in English
| MEDLINE | ID: mdl-33144881
16.
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical Oncologists.
Ecancermedicalscience
; 14: 1046, 2020.
Article
in English
| MEDLINE | ID: mdl-32565899
17.
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated?
Urol Oncol
; 37(12): 964-969, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31601517
18.
Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
Lung Cancer
; 61(3): 369-77, 2008 Sep.
Article
in English
| MEDLINE | ID: mdl-18308419
19.
Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience.
Clin Colorectal Cancer
; 5(6): 422-8, 2006 Mar.
Article
in English
| MEDLINE | ID: mdl-16635281
20.
Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
Anticancer Res
; 26(4B): 3143-50, 2006.
Article
in English
| MEDLINE | ID: mdl-16886648